XML 21 R48.htm IDEA: XBRL DOCUMENT v2.4.0.8
STOCK-BASED COMPENSATION (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
9 Months Ended 3 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended 12 Months Ended 9 Months Ended 3 Months Ended 9 Months Ended
Sep. 30, 2013
May 14, 2013
Sep. 30, 2013
ESPP
Sep. 30, 2013
ESPP
item
Nov. 09, 2010
ESPP
Sep. 30, 2013
Stock options
item
Sep. 30, 2013
Stock options
Dec. 31, 2012
Stock options
Sep. 30, 2013
Stock options
Minimum
Sep. 30, 2013
Stock options
Maximum
Sep. 30, 2013
Stock options
Vests 25%, 25% 50% over three years
item
Sep. 30, 2013
Restricted shares
Stock-based compensation                        
Number of shares reserved for issuance   6,200,000     500,000              
Vesting period                 3 years 4 years    
Expiration period             10 years          
Number of shares available for grant or purchase 1,894,749   482,021 482,021                
Number of options issued to purchase shares           50,000 50,000          
Exercise price of options issued (in dollars per share)           $ 2.27 $ 2.27          
Number of employees to whom options were issued           1            
Percentage of the award vesting on each of the first two anniversaries                     25.00%  
Percentage of the award vesting at third anniversary                     50.00%  
Number of anniversaries, initial vesting percentage                     2  
Assumptions used to estimate the fair values of the stock options granted                        
Risk-free interest rate (as a percent)           2.50%            
Expected volatility (as a percent)           58.90%            
Expected life           7 years 4 months 28 days            
Weighted-average estimated fair value of options granted during the period (in dollars per share)           $ 1.40 $ 1.40          
Term of U.S. Treasury zero-coupon strip 10 years                      
Expected amount of dividend to be distributed           $ 0            
Number of Shares                        
Outstanding at the beginning of the period (in shares)             3,929,910          
Options granted (in shares)           50,000 50,000          
Cancelled/forfeited (in shares)             (208,605)          
Outstanding at the end of the period (in shares)           3,771,305 3,771,305 3,929,910        
Vested and exercisable at the end of the period (in shares)           2,665,008 2,665,008          
Vested and exercisable at the end of the period and expected to vest thereafter (in shares)           3,771,305 3,771,305          
Weighted-Average Exercise Price                        
Outstanding at the beginning of the period (in dollars per share)             $ 9.03          
Options granted (in dollars per share)           $ 2.27 $ 2.27          
Canceled/forfeited (in dollars per share)             $ 5.43          
Outstanding at the end of the period (in dollars per share)           $ 9.13 $ 9.13 $ 9.03        
Vested and exercisable at the end of the period (in dollars per share)           $ 11.42 $ 11.42          
Vested and exercisable at the end of the period and expected to vest thereafter (in dollars per share)           $ 9.13 $ 9.13          
Weighted-Average Remaining Contractual Term (in years)                        
Outstanding at the end of the period             6 years 11 months 16 days 7 years 9 months        
Options granted             7 years 4 months 28 days          
Vested and exercisable at the end of the period             6 years 1 month 17 days          
Vested and exercisable at the end of the period and expected to vest thereafter             6 years 11 months 16 days          
Weighted-Average Grant-Date Fair Value                        
Outstanding (in dollars per share)           $ 3.87 $ 3.87 $ 3.84        
Options granted (in dollars per share)           $ 1.40 $ 1.40          
Canceled/forfeited (in dollars per share)             $ 2.85          
Vested and exercisable at the end of the period (in dollars per share)           $ 4.62 $ 4.62          
Vested and exercisable at the end of the period and expected to vest thereafter (in dollars per share)           $ 3.87 $ 3.87          
Aggregate Intrinsic Value                        
Outstanding at the beginning of the period             (26,723)          
Options granted             (2)          
Outstanding at the end of the period           (26,022) (26,022) (26,723)        
Vested and exercisable at the end of the period           (24,491) (24,491)          
Vested and exercisable at the end of the period and expected to vest thereafter           (26,022) (26,022)          
Stock-based compensation, additional disclosure                        
Closing stock price (in dollars per share) $ 2.23                      
Number of units                        
Unvested at the beginning of the period (in shares)                       128,060
Granted (in shares)                       169,237
Vested (in shares)                       (154,672)
Unvested at the end of the period (in shares)                       142,625
Expected to vest at the end of the period (in shares)                       142,625
Weighted-Average Grant-Date Fair Value                        
Unvested at the beginning of the period (in dollars per share)                       $ 7.46
Granted (in dollars per share)                       $ 2.64
Vested (in dollars per share)                       $ 4.01
Unvested at the end of the period (in dollars per share)                       $ 5.49
Expected to vest at the end of the period (in dollars per share)                       $ 5.49
Unrecognized compensation cost                        
Unrecognized compensation cost           1,612 1,612         612
Weighted-average remaining vesting period of recognition             1 year         1 year 6 months
2010 ESPP                        
Discount rate (as a percent)       10.00%                
Number of Offering periods       4                
Stock-based compensation expense     $ 0 $ 1